mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.01 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |